DaVita (NYSE:DVA) Upgraded at Zacks Research

Zacks Research upgraded shares of DaVita (NYSE:DVA) from a hold rating to a strong-buy rating in a research note published on Wednesday morning,Zacks.com reports.

Other analysts have also recently issued research reports about the stock. TD Cowen reissued a “hold” rating on shares of DaVita in a report on Tuesday. Barclays boosted their price target on shares of DaVita from $143.00 to $158.00 and gave the company an “equal weight” rating in a research report on Tuesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of DaVita in a report on Monday, December 29th. UBS Group boosted their target price on DaVita from $186.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday. Finally, Wall Street Zen cut DaVita from a “buy” rating to a “hold” rating in a research report on Saturday, October 11th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $160.50.

DaVita Price Performance

DaVita stock opened at $140.77 on Wednesday. The stock has a market cap of $9.94 billion, a PE ratio of 14.20, a P/E/G ratio of 0.52 and a beta of 0.99. The stock’s fifty day moving average is $115.12 and its two-hundred day moving average is $125.11. DaVita has a 1-year low of $101.00 and a 1-year high of $178.38.

DaVita (NYSE:DVA) last released its quarterly earnings data on Monday, February 2nd. The company reported $3.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.24 by $0.16. DaVita had a negative return on equity of 413.18% and a net margin of 5.47%.The business had revenue of $3.62 billion during the quarter, compared to analysts’ expectations of $3.51 billion. During the same period in the prior year, the firm posted $2.24 EPS. The business’s quarterly revenue was up 9.9% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 13.600-15.00 EPS. On average, research analysts expect that DaVita will post 10.76 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Hantz Financial Services Inc. grew its position in DaVita by 48.1% in the 2nd quarter. Hantz Financial Services Inc. now owns 231 shares of the company’s stock valued at $33,000 after buying an additional 75 shares during the last quarter. Mid American Wealth Advisory Group Inc. acquired a new stake in shares of DaVita in the 2nd quarter worth $36,000. Elevation Wealth Partners LLC boosted its holdings in shares of DaVita by 147.3% in the fourth quarter. Elevation Wealth Partners LLC now owns 277 shares of the company’s stock valued at $31,000 after acquiring an additional 165 shares in the last quarter. Canada Pension Plan Investment Board purchased a new position in DaVita during the second quarter worth about $43,000. Finally, Ameritas Advisory Services LLC acquired a new stake in DaVita in the second quarter valued at about $47,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.